PATHOBIOTEK DIAGNOSTICS INC/TX
10QSB, EX-27, 2000-11-20
NON-OPERATING ESTABLISHMENTS
Previous: PATHOBIOTEK DIAGNOSTICS INC/TX, 10QSB, 2000-11-20
Next: RBID COM INC, 10QSB, 2000-11-20



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                         129,209
<SECURITIES>                                   0
<RECEIVABLES>                                  2,158
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               131,367
<PP&E>                                         142,533
<DEPRECIATION>                                 (86,723)
<TOTAL-ASSETS>                                 248,878
<CURRENT-LIABILITIES>                          1,543,702
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       15,114
<OTHER-SE>                                     (1,309,938)
<TOTAL-LIABILITY-AND-EQUITY>                   248,878
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               678,927
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             2,499
<INCOME-PRETAX>                                (681,426)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (681,426)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (681,426)
<EPS-BASIC>                                    (.44)
<EPS-DILUTED>                                  (.44)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission